More than 75,000 Kaiser Permanente workers threaten strike if labor agreement not reached

More than 75,000 Kaiser Permanente workers threaten strike if labor agreement not reached


Thousands of healthcare workers march down Vermont to call for the urgent need for improved working conditions, better support systems and increased investment in the healthcare workforce at Kaiser Permanente Los Angeles Medical Center in Hollywood on Monday, Sept. 4, 2023 in Los Angeles, CA.

Dania Maxwell | Los Angeles Times | Getty Images

More than 75,000 workers at the largest nonprofit health-care provider in the United States threatened Friday to strike if an agreement is not reached to resolve a staffing crisis by the end of next week.

A union coalition warned Kaiser Permanente that its members will walk out for three days in October at hundreds of health facilities across California, Colorado, Oregon, Washington, Virginia and Washington D.C., if a deal is not reached to relieve the issue.

The Coalition of Kaiser Permanente Unions issued the ultimatum after their final bargaining session concluded without an apparent resolution.

The unions said they will go on strike from Oct. 4 to 6 if an agreement is not reached when their current contract expires Sept. 30.

Kaiser Permanente serves nearly 13 million patients. It operates 39 hospitals and more than 600 medical offices across eight states and the District of Columbia.

CNBC Health & Science

Read CNBC’s latest health coverage:

Dave Regan, president of SEIU-United Healthcare Workers West, said that Kaiser has failed to adequately address a staffing crisis that has led to dangerous wait times for patients.

“Kaiser executives refuse to acknowledge how much patient care has deteriorated or how much the frontline healthcare workforce and patients are suffering because of the Kaiser short-staffing crisis,” Regan said in a statement

The Coalition of Kaiser Permanente Unions’ membership includes medical assistants, surgical and lab technicians, pharmacists and administrative staff among other health-care workers. Several unions voted overwhelmingly to authorize strikes at Kaiser last week.

Kaiser has called the unions’ claims misleading and urged employees to resist a call for a strike.

“The Coalition unions are positioned to strike in October. However, for the last 26 years of our historic labor-management partnership, we have reached agreements with the Coalition every time, with no strikes. A strike notice does not mean a strike will happen,” Kaiser said in a statement.

“Our top priority is caring for our members and patients, and we have plans in place to ensure we can continue to provide, high-quality care should a strike actually occur,” Kaiser said. “To be clear, we will continue to bargain in good faith until we reach a fair and equitable agreement that strengthens our position as a best place to work and ensures that the high-quality care our members expect from us remains affordable and easy to access.”



Source

Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More
Making U.S. biotech more competitive with China’s could help rare disease patients, experts say
Health

Making U.S. biotech more competitive with China’s could help rare disease patients, experts say

The growth of China’s biotechnology sector has been staggering. Beijing is pumping money into the industry, backing research efforts and helping launch a new wave of labs and incubators in the country. That’s a problem for the U.S. biotech industry and also affects rare disease patients who are waiting for a cure. Among the experts […]

Read More